Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy.
Altschuler
Eric Lewin
EL
Bhatia
Ajay
A
Kast
Richard E
RE
D000081:Acetamides / Q000627:therapeutic use*; D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005922:Glomerulonephritis, IGA / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans / Q000627:therapeutic use*; D012794:Sialic Acids / Q000627:therapeutic use*; D053243:Zanamivir
D000081:Acetamides; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir